Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Paul Rothman, Kevin Watson, David Flannery

Premium

Cancer Genetics has appointed Paul Rothman, dean of the medical faculty and CEO of Johns Hopkins Medicine, to serve on its board of directors.

Rothman oversees the Johns Hopkins Health System and the School of Medicine, and before that he was dean of the University of Iowa's Carver College of Medicine. He also formerly was head of internal medicine at UI and vice chairman for research and founding director of the pulmonary, allergy, and critical care division at Columbia University College of Physicians.


Rosetta Genomics has appointed Kevin Watson to be director of reimbursement and managed care.

Watson joins Rosetta Genomics from BioTheranostics, where he was director of reimbursement. He formerly was president of GlobalPayer, a payer relations and reimbursement firm, and he spent six years in regional marketing and payer relations at Becton Dickinson Diagnostics – TriPath Imaging.


David Flannery, a pediatric geneticist, is the new medical director of the American College of Medical Genetics and Genomics.

Flannery is a founding fellow at ACMG, co-chair of its Economics of Genetic Services committee, as well as a member of its Professional Practice and Guidelines committee and CPT and Reimbursement subcommittee. He also represents ACMG on the American Medical Association's CPT advisory committee.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.